ClinConnect ClinConnect Logo
Search / Trial NCT06653998

Feasibility and Safety of Early Mobilization and Rehabilitation in Intensive Care Unit Patients

Launched by CLAUDIA ARISTIZÁBAL · Oct 21, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Intensive Care Units Muscle Weakness Early Mobilization Rehabilitation

ClinConnect Summary

This clinical trial is studying the safety and feasibility of getting patients up and moving early while they are in the Intensive Care Unit (ICU). Many patients in the ICU develop a condition called Intensive Care Unit Acquired Weakness (ICU-AW), which causes muscle weakness and can lead to longer recovery times and other health issues. By encouraging early mobilization and rehabilitation, the researchers hope to see if it can help patients recover better and faster.

To participate in the study, patients need to be at least 18 years old and currently admitted to the ICU. However, those who are extremely unstable, have certain serious medical conditions, or are recovering from specific surgeries may not be eligible. If you or a loved one joins the study, you can expect to be part of a supportive program aimed at getting you moving safely, which may help improve recovery outcomes. The study is currently recruiting participants, and it's being conducted in multiple hospitals to gather a wide range of data.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients ≥ 18 years of age admitted to the intensive care units.
  • Exclusion Criteria:
  • Patients requiring extracorporeal membrane oxygenation (ECMO).
  • Patients without indication for early mobilisation in the ICU (severe hemodynamic instability, acute brain or spinal injury with rest orders, anaemia (Hb \<8 mg/dl), thrombocytopenia (platelets \<50,000), active systemic inflammatory response according to institutional protocols).
  • Patients in the postoperative period of cardiac transplantation.

About Claudia Aristizábal

Claudia Aristizábal is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Claudia leads initiatives that bridge the gap between scientific discovery and clinical application. Her expertise encompasses protocol development, regulatory compliance, and stakeholder engagement, ensuring that trials are conducted with the highest standards of integrity and ethics. Through strategic collaborations and a patient-centered approach, Claudia aims to foster evidence-based advancements in healthcare, ultimately contributing to the betterment of community health and well-being.

Locations

Bogotá, Bogota, Colombia

Bogotá, Bogotá D.C., Colombia

Bogotá, Bogotá D.C., Colombia

Bogotá, Bogotá D.C., Colombia

Bogotá, , Colombia

Bogotá, , Colombia

Bogotá, , Colombia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported